Advanced Human Imaging Limited

NASDAQ:AHI

1.5 (USD) • At close July 25, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q2
Revenue 0.2460.1220.1340.521-0.0270.298-0.2750.8870.1540.0920.0560.0980.1871.5180.0280.006000.0040.004
Cost of Revenue 0.2461.494.1622.2643.1538.6095.6384.2481.4782.4211.672.1541.43213.0440.850.7650.6070.5070.1130.113
Gross Profit 0-1.367-4.028-1.744-3.18-8.311-5.913-3.361-1.324-2.329-1.614-2.057-1.245-11.526-0.822-0.759-0.607-0.507-0.109-0.109
Gross Profit Ratio 0-11.165-30.031-3.349117.289-27.87921.486-3.79-8.576-25.325-29.066-21.035-6.676-7.596-28.873-118.13100-31.044-31.044
Reseach & Development Expenses 000.2570000.23600.17200.17200.1950000.07900.0010.001
General & Administrative Expenses 01.2010.9982.6772.7291.7091.0490.6440.7950.6240.3650.5620.2990.6890.2550.3590.3440.3050.1380.138
Selling & Marketing Expenses 00.4130.4080.5021.0841.0230.6770.770.5420.7250.1670.1640.1830.1640.2470.1560.1290.1810.1890.189
SG&A 4.8536.533.2323.1795.1562.7321.7261.4141.2841.4030.8310.7960.9060.9130.7560.5790.5660.5840.3290.329
Other Expenses 00000000000000000000
Operating Expenses 4.8536.533.4233.4091.5846.9932.6052.7571.0241.2420.5670.5150.9330.7290.7170.5770.540.5570.3290.329
Operating Income -4.783-6.589-5.437-4.923-7.81-11.044-7.602-4.775-2.506-3.834-2.547-2.951-2.178-12.255-1.538-1.336-1.147-1.065-0.438-0.438
Operating Income Ratio -19.447-53.805-40.535-9.454288.047-37.04427.622-5.385-16.234-41.684-45.857-30.184-11.679-8.075-54.06-207.99600-124.67-124.67
Total Other Income Expenses Net 8.371-1.146-2.275-1.2423.095-4.319-0.988-1.4810.0550.2230.270.338-0.008-00.0160.0320.0660.03500
Income Before Tax 3.588-7.735-7.712-5.116-4.715-15.362-8.589-6.256-2.452-3.611-2.276-2.613-2.186-12.255-1.522-1.304-1.081-1.029-0.438-0.438
Income Before Tax Ratio 14.586-63.165-57.493-9.824173.89-51.53131.21-7.054-15.881-39.263-40.991-26.722-11.722-8.075-53.487-203.05800-124.67-124.67
Income Tax Expense 3.588-01.2091.2090.890.8900.78400.66600.53200.52200.6360.07000
Net Income 3.588-7.735-8.921-3.906-5.605-14.472-8.589-5.472-2.452-2.945-2.276-2.081-2.186-11.733-1.522-0.668-1.011-1.029-0.438-0.438
Net Income Ratio 14.586-63.165-66.509-7.502206.721-48.54531.21-6.17-15.881-32.019-40.991-21.284-11.722-7.732-53.487-103.96900-124.67-124.67
EPS 0.52-0.97-1.15-0.56-0.95-2.86-1.81-1.3-0.63-0.82-0.73-0.71-0.77-4.16-0.58-0.22-0.36-0.39-0.38-0.38
EPS Diluted 0.52-0.97-1.15-0.56-0.95-2.86-1.81-1.3-0.63-0.82-0.73-0.71-0.77-4.16-0.58-0.22-0.36-0.39-0.38-0.38
EBITDA -4.607-6.407-5.4-3.746-7.663-11.022-7.58-4.632-2.487-3.732-2.533-2.853-2.166-12.245-1.531-1.329-1.143-1.06200
EBITDA Ratio -18.729-52.321-40.258-7.195282.638-36.97227.543-5.223-16.109-40.577-45.606-29.179-11.611-8.069-53.794-207.0170000